Target intelligence / Profile preview

Melanoma antigen family A, 10 pseudogene

Molecular classification
Other (Pseudogene; not a receptor, enzyme, channel, transporter, or conventional gene product)
01

Overview

Melanoma antigen family A, 10 pseudogene (ENSG00000270794, also known as LOC100420324 or MAGEA10P) is a non-protein-coding member of the MAGEA gene family, classified as a pseudogene. The MAGEA family is best known for encoding cancer/testis antigens involved in oncogenesis and immune response, but pseudogenes like MAGEA10P do not produce functional proteins[5]. Some MAGEA pseudogenes may act as regulatory RNAs, potentially influencing cancer development or serving as miRNA decoys, but they are not considered direct therapeutic targets and are not currently targeted by drugs or immunotherapies[5].\n\nThere are functional MAGEA genes (e.g., MAGEA4, MAGEA10) that are under study as immunotherapy targets in cancer, but ENSG00000270794 is not one of them, as it is explicitly annotated as a pseudogene and does not code for a protein[1][3][4][5]. The nomenclature and roles of MAGEA pseudogenes are an area of ongoing molecular research, and while some literature references roles in gene regulation, these are largely indirect and not associated with direct molecular targeting by therapeutics[5].

Other names
LOC100420324MAGEA10Pmelanoma antigen family A, 10 pseudogene
02

Disease associations

Other (pseudogenes in the MAGEA family, including MAGEA10P, may regulate oncogenes by acting as miRNA decoys, potentially influencing cancer biology indirectly[5])

Beyond the preview

Go deeper on Melanoma antigen family A, 10 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Melanoma antigen family A, 10 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call